Brief: Zylox-Tonbridge Medical Technology Announces Licensing & Investment Agreements With Avinger
March 7 (Reuters) - Zylox-Tonbridge Medical Technology
Co Ltd 2190.HK :
* LICENSING AND INVESTMENT AGREEMENTS WITH AVINGER INC.
* UNDER AGREEMENT, CO WILL INVEST US$15.0 MLN INTO AVINGER
* UNDER DEAL, CO RECEIVES EXCLUSIVE RIGHT TO COMMERCIALIZE
OPTICAL
COHERENCE TOMOGRAPHY CONSOLES
Further company coverage: 2190.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY
See all newsChinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansion
Brief: Zylox-Tonbridge Medical Technology Profit For Year Rmb244.4 Mln
Brief: Zylox-Tonbridge Medical Technology Sees Revenue More Than RMB1.05 Billion For Year
Brief: Zylox-Tonbridge Medical Technology Announces Acquisition Of 49% Stake in Optimed Holding GmbH
Brief: Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per Share